PDS Biotechnology Corp
Change company Symbol lookup
Select an option...
PDSB PDS Biotechnology Corp
PG Procter & Gamble Co
LVS Las Vegas Sands Corp
AMP Ameriprise Financial Inc
SPHD Invesco S&P 500® High Dividend Low Volatility ETF
MRK Merck & Co Inc
HD Home Depot Inc
SQM Sociedad Quimica y Minera de Chile SA
AVGO Broadcom Inc
O Realty Income Corp
Go

Health Care : Biotechnology | Small Cap Value
Company profile

PDS Biotechnology Corp, formerly Edge Therapeutics, Inc., is an immuno-oncology company, The Company is focused on developing a pipeline of clinical-stage immunotherapies. Its therapies are developed for the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Versamune is its synthetic lipid-based immunotherapy platform. Its lead product candidate, PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. Its pipeline also includes PDS0102, PDS0103 and PDS0104. Its pipeline of Versamune-based products are all administered by subcutaneous injection .DS0102 is being developed for the treatment of prostate and breast cancers. PDS0103 is based on novel agonist antigens of the mucin-1 (MUC-1) oncogenic C-terminal region. PDS0104 is being developed for the treatment of melanoma.

Closing Price
$2.16
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
279,747
0
  • Prev Close
    2.16
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    279.7K
  • Last (time)
    3:59p ET 11/30/20
  • Last (size)
    2
  • 52-Wk Range
    0.6153 - 4.98
    LowHigh
  • (04/02/20 - 08/04/20)
    251.05%
  • 136.1%
  • Market Cap
    48.1M
  • Shares Outstanding
    22.3M
  • -1.57
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 2.7
  • 14.76
  • (% of float 11/15/20)
    2.42

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.